1 Introduction to Research & Analysis Reports
1.1 Parkinsons Disease Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Parkinsons Disease Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Parkinsons Disease Drug Overall Market Size
2.1 Global Parkinsons Disease Drug Market Size: 2022 VS 2029
2.2 Global Parkinsons Disease Drug Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Parkinsons Disease Drug Sales: 2018-2029
3 Company Landscape
3.1 Top Parkinsons Disease Drug Players in Global Market
3.2 Top Global Parkinsons Disease Drug Companies Ranked by Revenue
3.3 Global Parkinsons Disease Drug Revenue by Companies
3.4 Global Parkinsons Disease Drug Sales by Companies
3.5 Global Parkinsons Disease Drug Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Parkinsons Disease Drug Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Parkinsons Disease Drug Product Type
3.8 Tier 1, Tier 2 and Tier 3 Parkinsons Disease Drug Players in Global Market
3.8.1 List of Global Tier 1 Parkinsons Disease Drug Companies
3.8.2 List of Global Tier 2 and Tier 3 Parkinsons Disease Drug Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Parkinsons Disease Drug Market Size Markets, 2022 & 2029
4.1.2 Carbidopa/Levodopa
4.1.3 Dopamine Receptor Agonists
4.1.4 MAO-Inhibitors
4.2 By Type – Global Parkinsons Disease Drug Revenue & Forecasts
4.2.1 By Type – Global Parkinsons Disease Drug Revenue, 2018-2023
4.2.2 By Type – Global Parkinsons Disease Drug Revenue, 2024-2029
4.2.3 By Type – Global Parkinsons Disease Drug Revenue Market Share, 2018-2029
4.3 By Type – Global Parkinsons Disease Drug Sales & Forecasts
4.3.1 By Type – Global Parkinsons Disease Drug Sales, 2018-2023
4.3.2 By Type – Global Parkinsons Disease Drug Sales, 2024-2029
4.3.3 By Type – Global Parkinsons Disease Drug Sales Market Share, 2018-2029
4.4 By Type – Global Parkinsons Disease Drug Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Parkinsons Disease Drug Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Clinics
5.1.4 Other
5.2 By Application – Global Parkinsons Disease Drug Revenue & Forecasts
5.2.1 By Application – Global Parkinsons Disease Drug Revenue, 2018-2023
5.2.2 By Application – Global Parkinsons Disease Drug Revenue, 2024-2029
5.2.3 By Application – Global Parkinsons Disease Drug Revenue Market Share, 2018-2029
5.3 By Application – Global Parkinsons Disease Drug Sales & Forecasts
5.3.1 By Application – Global Parkinsons Disease Drug Sales, 2018-2023
5.3.2 By Application – Global Parkinsons Disease Drug Sales, 2024-2029
5.3.3 By Application – Global Parkinsons Disease Drug Sales Market Share, 2018-2029
5.4 By Application – Global Parkinsons Disease Drug Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Parkinsons Disease Drug Market Size, 2022 & 2029
6.2 By Region – Global Parkinsons Disease Drug Revenue & Forecasts
6.2.1 By Region – Global Parkinsons Disease Drug Revenue, 2018-2023
6.2.2 By Region – Global Parkinsons Disease Drug Revenue, 2024-2029
6.2.3 By Region – Global Parkinsons Disease Drug Revenue Market Share, 2018-2029
6.3 By Region – Global Parkinsons Disease Drug Sales & Forecasts
6.3.1 By Region – Global Parkinsons Disease Drug Sales, 2018-2023
6.3.2 By Region – Global Parkinsons Disease Drug Sales, 2024-2029
6.3.3 By Region – Global Parkinsons Disease Drug Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Parkinsons Disease Drug Revenue, 2018-2029
6.4.2 By Country – North America Parkinsons Disease Drug Sales, 2018-2029
6.4.3 US Parkinsons Disease Drug Market Size, 2018-2029
6.4.4 Canada Parkinsons Disease Drug Market Size, 2018-2029
6.4.5 Mexico Parkinsons Disease Drug Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Parkinsons Disease Drug Revenue, 2018-2029
6.5.2 By Country – Europe Parkinsons Disease Drug Sales, 2018-2029
6.5.3 Germany Parkinsons Disease Drug Market Size, 2018-2029
6.5.4 France Parkinsons Disease Drug Market Size, 2018-2029
6.5.5 U.K. Parkinsons Disease Drug Market Size, 2018-2029
6.5.6 Italy Parkinsons Disease Drug Market Size, 2018-2029
6.5.7 Russia Parkinsons Disease Drug Market Size, 2018-2029
6.5.8 Nordic Countries Parkinsons Disease Drug Market Size, 2018-2029
6.5.9 Benelux Parkinsons Disease Drug Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Parkinsons Disease Drug Revenue, 2018-2029
6.6.2 By Region – Asia Parkinsons Disease Drug Sales, 2018-2029
6.6.3 China Parkinsons Disease Drug Market Size, 2018-2029
6.6.4 Japan Parkinsons Disease Drug Market Size, 2018-2029
6.6.5 South Korea Parkinsons Disease Drug Market Size, 2018-2029
6.6.6 Southeast Asia Parkinsons Disease Drug Market Size, 2018-2029
6.6.7 India Parkinsons Disease Drug Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Parkinsons Disease Drug Revenue, 2018-2029
6.7.2 By Country – South America Parkinsons Disease Drug Sales, 2018-2029
6.7.3 Brazil Parkinsons Disease Drug Market Size, 2018-2029
6.7.4 Argentina Parkinsons Disease Drug Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Parkinsons Disease Drug Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Parkinsons Disease Drug Sales, 2018-2029
6.8.3 Turkey Parkinsons Disease Drug Market Size, 2018-2029
6.8.4 Israel Parkinsons Disease Drug Market Size, 2018-2029
6.8.5 Saudi Arabia Parkinsons Disease Drug Market Size, 2018-2029
6.8.6 UAE Parkinsons Disease Drug Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Teva
7.1.1 Teva Company Summary
7.1.2 Teva Business Overview
7.1.3 Teva Parkinsons Disease Drug Major Product Offerings
7.1.4 Teva Parkinsons Disease Drug Sales and Revenue in Global (2018-2023)
7.1.5 Teva Key News & Latest Developments
7.2 Novartis AG
7.2.1 Novartis AG Company Summary
7.2.2 Novartis AG Business Overview
7.2.3 Novartis AG Parkinsons Disease Drug Major Product Offerings
7.2.4 Novartis AG Parkinsons Disease Drug Sales and Revenue in Global (2018-2023)
7.2.5 Novartis AG Key News & Latest Developments
7.3 GSK
7.3.1 GSK Company Summary
7.3.2 GSK Business Overview
7.3.3 GSK Parkinsons Disease Drug Major Product Offerings
7.3.4 GSK Parkinsons Disease Drug Sales and Revenue in Global (2018-2023)
7.3.5 GSK Key News & Latest Developments
7.4 AbbVie
7.4.1 AbbVie Company Summary
7.4.2 AbbVie Business Overview
7.4.3 AbbVie Parkinsons Disease Drug Major Product Offerings
7.4.4 AbbVie Parkinsons Disease Drug Sales and Revenue in Global (2018-2023)
7.4.5 AbbVie Key News & Latest Developments
7.5 Merck
7.5.1 Merck Company Summary
7.5.2 Merck Business Overview
7.5.3 Merck Parkinsons Disease Drug Major Product Offerings
7.5.4 Merck Parkinsons Disease Drug Sales and Revenue in Global (2018-2023)
7.5.5 Merck Key News & Latest Developments
7.6 Boehringer Ingelheim
7.6.1 Boehringer Ingelheim Company Summary
7.6.2 Boehringer Ingelheim Business Overview
7.6.3 Boehringer Ingelheim Parkinsons Disease Drug Major Product Offerings
7.6.4 Boehringer Ingelheim Parkinsons Disease Drug Sales and Revenue in Global (2018-2023)
7.6.5 Boehringer Ingelheim Key News & Latest Developments
7.7 Impax Laboratories
7.7.1 Impax Laboratories Company Summary
7.7.2 Impax Laboratories Business Overview
7.7.3 Impax Laboratories Parkinsons Disease Drug Major Product Offerings
7.7.4 Impax Laboratories Parkinsons Disease Drug Sales and Revenue in Global (2018-2023)
7.7.5 Impax Laboratories Key News & Latest Developments
7.8 Lundbeck
7.8.1 Lundbeck Company Summary
7.8.2 Lundbeck Business Overview
7.8.3 Lundbeck Parkinsons Disease Drug Major Product Offerings
7.8.4 Lundbeck Parkinsons Disease Drug Sales and Revenue in Global (2018-2023)
7.8.5 Lundbeck Key News & Latest Developments
7.9 Sun Pharma
7.9.1 Sun Pharma Company Summary
7.9.2 Sun Pharma Business Overview
7.9.3 Sun Pharma Parkinsons Disease Drug Major Product Offerings
7.9.4 Sun Pharma Parkinsons Disease Drug Sales and Revenue in Global (2018-2023)
7.9.5 Sun Pharma Key News & Latest Developments
7.10 Wockhardt
7.10.1 Wockhardt Company Summary
7.10.2 Wockhardt Business Overview
7.10.3 Wockhardt Parkinsons Disease Drug Major Product Offerings
7.10.4 Wockhardt Parkinsons Disease Drug Sales and Revenue in Global (2018-2023)
7.10.5 Wockhardt Key News & Latest Developments
7.11 UCB
7.11.1 UCB Company Summary
7.11.2 UCB Parkinsons Disease Drug Business Overview
7.11.3 UCB Parkinsons Disease Drug Major Product Offerings
7.11.4 UCB Parkinsons Disease Drug Sales and Revenue in Global (2018-2023)
7.11.5 UCB Key News & Latest Developments
7.12 Bausch Health
7.12.1 Bausch Health Company Summary
7.12.2 Bausch Health Parkinsons Disease Drug Business Overview
7.12.3 Bausch Health Parkinsons Disease Drug Major Product Offerings
7.12.4 Bausch Health Parkinsons Disease Drug Sales and Revenue in Global (2018-2023)
7.12.5 Bausch Health Key News & Latest Developments
7.13 Acadia
7.13.1 Acadia Company Summary
7.13.2 Acadia Parkinsons Disease Drug Business Overview
7.13.3 Acadia Parkinsons Disease Drug Major Product Offerings
7.13.4 Acadia Parkinsons Disease Drug Sales and Revenue in Global (2018-2023)
7.13.5 Acadia Key News & Latest Developments
8 Global Parkinsons Disease Drug Production Capacity, Analysis
8.1 Global Parkinsons Disease Drug Production Capacity, 2018-2029
8.2 Parkinsons Disease Drug Production Capacity of Key Manufacturers in Global Market
8.3 Global Parkinsons Disease Drug Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Parkinsons Disease Drug Supply Chain Analysis
10.1 Parkinsons Disease Drug Industry Value Chain
10.2 Parkinsons Disease Drug Upstream Market
10.3 Parkinsons Disease Drug Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Parkinsons Disease Drug Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
Table 1. Key Players of Parkinsons Disease Drug in Global Market
Table 2. Top Parkinsons Disease Drug Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Parkinsons Disease Drug Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Parkinsons Disease Drug Revenue Share by Companies, 2018-2023
Table 5. Global Parkinsons Disease Drug Sales by Companies, (K Doses), 2018-2023
Table 6. Global Parkinsons Disease Drug Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Parkinsons Disease Drug Price (2018-2023) & (USD/Dose)
Table 8. Global Manufacturers Parkinsons Disease Drug Product Type
Table 9. List of Global Tier 1 Parkinsons Disease Drug Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Parkinsons Disease Drug Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Parkinsons Disease Drug Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Parkinsons Disease Drug Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Parkinsons Disease Drug Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Parkinsons Disease Drug Sales (K Doses), 2018-2023
Table 15. By Type - Global Parkinsons Disease Drug Sales (K Doses), 2024-2029
Table 16. By Application – Global Parkinsons Disease Drug Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Parkinsons Disease Drug Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Parkinsons Disease Drug Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Parkinsons Disease Drug Sales (K Doses), 2018-2023
Table 20. By Application - Global Parkinsons Disease Drug Sales (K Doses), 2024-2029
Table 21. By Region – Global Parkinsons Disease Drug Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Parkinsons Disease Drug Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Parkinsons Disease Drug Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Parkinsons Disease Drug Sales (K Doses), 2018-2023
Table 25. By Region - Global Parkinsons Disease Drug Sales (K Doses), 2024-2029
Table 26. By Country - North America Parkinsons Disease Drug Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Parkinsons Disease Drug Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Parkinsons Disease Drug Sales, (K Doses), 2018-2023
Table 29. By Country - North America Parkinsons Disease Drug Sales, (K Doses), 2024-2029
Table 30. By Country - Europe Parkinsons Disease Drug Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Parkinsons Disease Drug Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Parkinsons Disease Drug Sales, (K Doses), 2018-2023
Table 33. By Country - Europe Parkinsons Disease Drug Sales, (K Doses), 2024-2029
Table 34. By Region - Asia Parkinsons Disease Drug Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Parkinsons Disease Drug Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Parkinsons Disease Drug Sales, (K Doses), 2018-2023
Table 37. By Region - Asia Parkinsons Disease Drug Sales, (K Doses), 2024-2029
Table 38. By Country - South America Parkinsons Disease Drug Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Parkinsons Disease Drug Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Parkinsons Disease Drug Sales, (K Doses), 2018-2023
Table 41. By Country - South America Parkinsons Disease Drug Sales, (K Doses), 2024-2029
Table 42. By Country - Middle East & Africa Parkinsons Disease Drug Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Parkinsons Disease Drug Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Parkinsons Disease Drug Sales, (K Doses), 2018-2023
Table 45. By Country - Middle East & Africa Parkinsons Disease Drug Sales, (K Doses), 2024-2029
Table 46. Teva Company Summary
Table 47. Teva Parkinsons Disease Drug Product Offerings
Table 48. Teva Parkinsons Disease Drug Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 49. Teva Key News & Latest Developments
Table 50. Novartis AG Company Summary
Table 51. Novartis AG Parkinsons Disease Drug Product Offerings
Table 52. Novartis AG Parkinsons Disease Drug Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 53. Novartis AG Key News & Latest Developments
Table 54. GSK Company Summary
Table 55. GSK Parkinsons Disease Drug Product Offerings
Table 56. GSK Parkinsons Disease Drug Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 57. GSK Key News & Latest Developments
Table 58. AbbVie Company Summary
Table 59. AbbVie Parkinsons Disease Drug Product Offerings
Table 60. AbbVie Parkinsons Disease Drug Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 61. AbbVie Key News & Latest Developments
Table 62. Merck Company Summary
Table 63. Merck Parkinsons Disease Drug Product Offerings
Table 64. Merck Parkinsons Disease Drug Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 65. Merck Key News & Latest Developments
Table 66. Boehringer Ingelheim Company Summary
Table 67. Boehringer Ingelheim Parkinsons Disease Drug Product Offerings
Table 68. Boehringer Ingelheim Parkinsons Disease Drug Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 69. Boehringer Ingelheim Key News & Latest Developments
Table 70. Impax Laboratories Company Summary
Table 71. Impax Laboratories Parkinsons Disease Drug Product Offerings
Table 72. Impax Laboratories Parkinsons Disease Drug Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 73. Impax Laboratories Key News & Latest Developments
Table 74. Lundbeck Company Summary
Table 75. Lundbeck Parkinsons Disease Drug Product Offerings
Table 76. Lundbeck Parkinsons Disease Drug Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 77. Lundbeck Key News & Latest Developments
Table 78. Sun Pharma Company Summary
Table 79. Sun Pharma Parkinsons Disease Drug Product Offerings
Table 80. Sun Pharma Parkinsons Disease Drug Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 81. Sun Pharma Key News & Latest Developments
Table 82. Wockhardt Company Summary
Table 83. Wockhardt Parkinsons Disease Drug Product Offerings
Table 84. Wockhardt Parkinsons Disease Drug Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 85. Wockhardt Key News & Latest Developments
Table 86. UCB Company Summary
Table 87. UCB Parkinsons Disease Drug Product Offerings
Table 88. UCB Parkinsons Disease Drug Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 89. UCB Key News & Latest Developments
Table 90. Bausch Health Company Summary
Table 91. Bausch Health Parkinsons Disease Drug Product Offerings
Table 92. Bausch Health Parkinsons Disease Drug Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 93. Bausch Health Key News & Latest Developments
Table 94. Acadia Company Summary
Table 95. Acadia Parkinsons Disease Drug Product Offerings
Table 96. Acadia Parkinsons Disease Drug Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 97. Acadia Key News & Latest Developments
Table 98. Parkinsons Disease Drug Production Capacity (K Doses) of Key Manufacturers in Global Market, 2021-2023 (K Doses)
Table 99. Global Parkinsons Disease Drug Capacity Market Share of Key Manufacturers, 2021-2023
Table 100. Global Parkinsons Disease Drug Production by Region, 2018-2023 (K Doses)
Table 101. Global Parkinsons Disease Drug Production by Region, 2024-2029 (K Doses)
Table 102. Parkinsons Disease Drug Market Opportunities & Trends in Global Market
Table 103. Parkinsons Disease Drug Market Drivers in Global Market
Table 104. Parkinsons Disease Drug Market Restraints in Global Market
Table 105. Parkinsons Disease Drug Raw Materials
Table 106. Parkinsons Disease Drug Raw Materials Suppliers in Global Market
Table 107. Typical Parkinsons Disease Drug Downstream
Table 108. Parkinsons Disease Drug Downstream Clients in Global Market
Table 109. Parkinsons Disease Drug Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Parkinsons Disease Drug Segment by Type in 2022
Figure 2. Parkinsons Disease Drug Segment by Application in 2022
Figure 3. Global Parkinsons Disease Drug Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Parkinsons Disease Drug Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Parkinsons Disease Drug Revenue, 2018-2029 (US$, Mn)
Figure 7. Parkinsons Disease Drug Sales in Global Market: 2018-2029 (K Doses)
Figure 8. The Top 3 and 5 Players Market Share by Parkinsons Disease Drug Revenue in 2022
Figure 9. By Type - Global Parkinsons Disease Drug Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Parkinsons Disease Drug Revenue Market Share, 2018-2029
Figure 11. By Type - Global Parkinsons Disease Drug Sales Market Share, 2018-2029
Figure 12. By Type - Global Parkinsons Disease Drug Price (USD/Dose), 2018-2029
Figure 13. By Application - Global Parkinsons Disease Drug Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Parkinsons Disease Drug Revenue Market Share, 2018-2029
Figure 15. By Application - Global Parkinsons Disease Drug Sales Market Share, 2018-2029
Figure 16. By Application - Global Parkinsons Disease Drug Price (USD/Dose), 2018-2029
Figure 17. By Region - Global Parkinsons Disease Drug Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Parkinsons Disease Drug Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Parkinsons Disease Drug Revenue Market Share, 2018-2029
Figure 20. By Region - Global Parkinsons Disease Drug Sales Market Share, 2018-2029
Figure 21. By Country - North America Parkinsons Disease Drug Revenue Market Share, 2018-2029
Figure 22. By Country - North America Parkinsons Disease Drug Sales Market Share, 2018-2029
Figure 23. US Parkinsons Disease Drug Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Parkinsons Disease Drug Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Parkinsons Disease Drug Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Parkinsons Disease Drug Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Parkinsons Disease Drug Sales Market Share, 2018-2029
Figure 28. Germany Parkinsons Disease Drug Revenue, (US$, Mn), 2018-2029
Figure 29. France Parkinsons Disease Drug Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Parkinsons Disease Drug Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Parkinsons Disease Drug Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Parkinsons Disease Drug Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Parkinsons Disease Drug Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Parkinsons Disease Drug Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Parkinsons Disease Drug Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Parkinsons Disease Drug Sales Market Share, 2018-2029
Figure 37. China Parkinsons Disease Drug Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Parkinsons Disease Drug Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Parkinsons Disease Drug Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Parkinsons Disease Drug Revenue, (US$, Mn), 2018-2029
Figure 41. India Parkinsons Disease Drug Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Parkinsons Disease Drug Revenue Market Share, 2018-2029
Figure 43. By Country - South America Parkinsons Disease Drug Sales Market Share, 2018-2029
Figure 44. Brazil Parkinsons Disease Drug Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Parkinsons Disease Drug Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Parkinsons Disease Drug Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Parkinsons Disease Drug Sales Market Share, 2018-2029
Figure 48. Turkey Parkinsons Disease Drug Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Parkinsons Disease Drug Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Parkinsons Disease Drug Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Parkinsons Disease Drug Revenue, (US$, Mn), 2018-2029
Figure 52. Global Parkinsons Disease Drug Production Capacity (K Doses), 2018-2029
Figure 53. The Percentage of Production Parkinsons Disease Drug by Region, 2022 VS 2029
Figure 54. Parkinsons Disease Drug Industry Value Chain
Figure 55. Marketing Channels
| ※参考情報 パーキンソン病用薬剤は、パーキンソン病という神経変性疾患の症状を緩和するために使用される医薬品です。パーキンソン病は、ドパミンを産生する神経細胞の変性によって引き起こされる疾患で、主に運動機能に影響を及ぼします。主な症状には、震え、筋肉の硬直、動作の遅延が含まれます。この病気は通常、中高年の人々に発症することが多いですが、若年性パーキンソン病も存在します。 パーキンソン病用薬剤の定義は、パーキンソン病による運動症状を緩和または改善するために処方される薬剤の総称です。これらの薬剤は、病気の根本的な治療法ではなく、あくまで症状緩和を目的としています。 パーキンソン病用薬剤の特徴として、様々な種類があることが挙げられます。使用する薬剤は患者の症状や病歴によって異なり、効果や副作用も個々に異なります。主に利用される薬剤に関しては、以下のような分類ができます。 まず、レボドパ（L-DOPA）という薬剤が挙げられます。レボドパは、ドパミンの前駆体であり、脳内でドパミンに変換されることで、運動機能の改善を図る効果があります。レボドパは特に初期の段階から使用されることが多く、非常に効果的な薬剤ではありますが、長期間の使用により運動合併症が発生する可能性があります。そのため、他の薬剤と併用して使用されることが一般的です。 次に、ドパミンアゴニストが挙げられます。これはドパミン受容体に直接作用し、ドパミンの作用を模倣する薬剤です。ブロモクリプチン、プラミペキソール、ロピニロールなどがあります。ドパミンアゴニストは、特に若年性の患者において、レボドパを使用する前に試みられることが多いです。長期使用時の副作用のリスクはありますが、動きの急激な増加を防ぐためにも有意義と言えます。 次に、COMT阻害剤もあります。カテコール-O-メチルトランスフェラーゼ（COMT）は、ドパミンの分解を促進する酵素です。COMT阻害剤は、この酵素の働きを妨げることで、脳内のドパミン濃度を高め、運動症状を緩和する効果があります。タスフレカト、エンタカポンなどがそれに該当します。 また、MAO-B阻害剤も重要なパーキンソン病用薬剤の一つです。モノアミンオキシダーゼB（MAO-B）は、脳内のドパミンを分解する酵素であり、それを抑えることで血中におけるドパミンレベルを維持し、症状の改善を図ります。セレギリンやラサギリンがMAO-B阻害剤に該当します。 さらに、抗コリン薬もパーキンソン病の一部の症状に対して効果があります。これらは主に震えに対して効果的ですが、副作用としては認知機能の低下が懸念されるため、注意が必要です。トリヘキシフェニジルやプロシクリジンなどが抗コリン薬として知られています。 パーキンソン病用薬剤の用途は、主に運動症状の改善です。そのほかにも、非運動症状―例えばうつ、不安、睡眠障害―に関しても症状を軽減するための薬剤が開発されています。近年は、パーキンソン病における非運動症状への認識が高まっており、これに対する治療も重要視されています。 関連技術としては、深部脳刺激（DBS）があります。これは、電極を脳内に埋め込み、特定の部位に電気刺激を加えることで運動症状を改善する技術です。DBSは、薬剤による効果が乏しい患者に対して行われることが多く、自動調整機能を持つ装置も開発されています。 パーキンソン病用薬剤は、単独でも使用されますが、患者の症状や副作用に応じて、複数併用されることが一般的です。その際には、効果の相乗効果や副作用の管理が重要になります。 パーキンソン病用薬剤の研究は進行中であり、新しい薬剤や治療法の開発が行われています。最近では、遺伝子治療や幹細胞治療などが注目されており、将来的にはより根本的な治療法が確立されることが期待されています。 以上が、パーキンソン病用薬剤の概念、種類、特徴、用途、関連技術などについての概略です。それぞれの薬剤は、患者の状態に応じて適切に選択されるべきであり、常に医師との相談が求められます。今後の研究により、さらに効果的な療法が登場することを期待しています。 |
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
